Added to YB: 2021-02-06
Pitch date: 2021-02-06
ASND [bullish]
Ascendis Pharma A/S
+39.37%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.
Market Cap
$10.8B
Pitch Price
$153.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
-49.78
P/E
-38.69
EV/Sales
22.59
Sector
Biotechnology
Category
N/A
Show full summary:
ASCENDIS PHARMA AS ASND
A summary for this pitch has not been created yet.
Read full article (0 min)